These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 27097221)

  • 1. Beneficial Effects of Sarpogrelate and Rosuvastatin in High Fat Diet/Streptozotocin-Induced Nephropathy in Mice.
    Kim DH; Choi BH; Ku SK; Park JH; Oh E; Kwak MK
    PLoS One; 2016; 11(4):e0153965. PubMed ID: 27097221
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combinational Use of Antiplatelet Medication Sarpogrelate with Therapeutic Drug Rosuvastatin in Treating High-Cholesterol Diet-Induced Chronic Kidney Disease in ApoE-Deficient Mice.
    Xu J; Pei Z; Yu M; Li X; Wang L; Lin Y; Chen X; Liu X
    Biomed Res Int; 2020; 2020():1809326. PubMed ID: 33029491
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amelioration of high fat diet-induced nephropathy by cilostazol and rosuvastatin.
    Park JH; Choi BH; Ku SK; Kim DH; Jung KA; Oh E; Kwak MK
    Arch Pharm Res; 2017 Mar; 40(3):391-402. PubMed ID: 28084586
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A 5-hydroxytryptamine receptor antagonist, sarpogrelate, reduces renal tubulointerstitial fibrosis by suppressing PAI-1.
    Hamasaki Y; Doi K; Maeda-Mamiya R; Ogasawara E; Katagiri D; Tanaka T; Yamamoto T; Sugaya T; Nangaku M; Noiri E
    Am J Physiol Renal Physiol; 2013 Dec; 305(12):F1796-803. PubMed ID: 24107419
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renal Protective Effects of Low Molecular Weight of Inonotus obliquus Polysaccharide (LIOP) on HFD/STZ-Induced Nephropathy in Mice.
    Chou YJ; Kan WC; Chang CM; Peng YJ; Wang HY; Yu WC; Cheng YH; Jhang YR; Liu HW; Chuu JJ
    Int J Mol Sci; 2016 Sep; 17(9):. PubMed ID: 27649140
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Negative correlation of urinary miR-199a-3p level with ameliorating effects of sarpogrelate and cilostazol in hypertensive diabetic nephropathy.
    Kim SK; Kim G; Choi BH; Ryu D; Ku SK; Kwak MK
    Biochem Pharmacol; 2021 Feb; 184():114391. PubMed ID: 33359069
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blockade of serotonin 2A receptor improves glomerular endothelial function in rats with streptozotocin-induced diabetic nephropathy.
    Kobayashi S; Satoh M; Namikoshi T; Haruna Y; Fujimoto S; Arakawa S; Komai N; Tomita N; Sasaki T; Kashihara N
    Clin Exp Nephrol; 2008 Apr; 12(2):119-125. PubMed ID: 18175064
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of sarpogrelate on altered STZ-diabetes induced cardiovascular responses to 5-hydroxytryptamine in rats.
    Umrani DN; Bodiwala DN; Goyal RK
    Mol Cell Biochem; 2003 Jul; 249(1-2):53-7. PubMed ID: 12956398
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Andrographolide ameliorates diabetic nephropathy by attenuating hyperglycemia-mediated renal oxidative stress and inflammation via Akt/NF-κB pathway.
    Ji X; Li C; Ou Y; Li N; Yuan K; Yang G; Chen X; Yang Z; Liu B; Cheung WW; Wang L; Huang R; Lan T
    Mol Cell Endocrinol; 2016 Dec; 437():268-279. PubMed ID: 27378149
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rosuvastatin as a potential preventive drug for the development of hepatocellular carcinoma associated with non-alcoholic fatty liver disease in mice.
    Yokohama K; Fukunishi S; Ii M; Nakamura K; Ohama H; Tsuchimoto Y; Asai A; Tsuda Y; Higuchi K
    Int J Mol Med; 2016 Nov; 38(5):1499-1506. PubMed ID: 28025996
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The anti-inflammation effect of Moutan Cortex on advanced glycation end products-induced rat mesangial cells dysfunction and High-glucose-fat diet and streptozotocin-induced diabetic nephropathy rats.
    Zhang MH; Feng L; Zhu MM; Gu JF; Jiang J; Cheng XD; Ding SM; Wu C; Jia XB
    J Ethnopharmacol; 2014; 151(1):591-600. PubMed ID: 24269777
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elafibranor Inhibits Chronic Kidney Disease Progression in NASH Mice.
    Tsai HC; Chang FP; Li TH; Liu CW; Huang CC; Huang SF; Yang YY; Lee KC; Hsieh YC; Wang YW; Lee TY; Huang YH; Hou MC; Lin HC
    Biomed Res Int; 2019; 2019():6740616. PubMed ID: 31321239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of serotonin in angiogenesis: induction of angiogenesis by sarpogrelate via endothelial 5-HT1B/Akt/eNOS pathway in diabetic mice.
    Iwabayashi M; Taniyama Y; Sanada F; Azuma J; Iekushi K; Kusunoki H; Chatterjee A; Okayama K; Rakugi H; Morishita R
    Atherosclerosis; 2012 Feb; 220(2):337-42. PubMed ID: 22172591
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Positive feedback loop between plasminogen activator inhibitor-1 and transforming growth factor-beta1 during renal fibrosis in diabetes.
    Seo JY; Park J; Yu MR; Kim YS; Ha H; Lee HB
    Am J Nephrol; 2009; 30(6):481-90. PubMed ID: 19786738
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reactive oxygen species mediate high glucose-induced plasminogen activator inhibitor-1 up-regulation in mesangial cells and in diabetic kidney.
    Lee EA; Seo JY; Jiang Z; Yu MR; Kwon MK; Ha H; Lee HB
    Kidney Int; 2005 May; 67(5):1762-71. PubMed ID: 15840023
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bradykinin inhibits high glucose- and growth factor-induced collagen synthesis in mesangial cells through the B2-kinin receptor.
    Blaes N; Pécher C; Mehrenberger M; Cellier E; Praddaude F; Chevalier J; Tack I; Couture R; Girolami JP
    Am J Physiol Renal Physiol; 2012 Jul; 303(2):F293-303. PubMed ID: 22573379
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of eplerenone, enalapril and their combination treatment on diabetic nephropathy in type II diabetic rats.
    Kang YS; Ko GJ; Lee MH; Song HK; Han SY; Han KH; Kim HK; Han JY; Cha DR
    Nephrol Dial Transplant; 2009 Jan; 24(1):73-84. PubMed ID: 18682491
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sarpogrelate and rosuvastatin synergistically ameliorate aortic damage induced by hyperlipidemia in apolipoprotein E-deficient mice.
    Liu H; Xu S; Li G; Lou D; Fu X; Lu Q; Hao L; Zhang J; Mei J; Sui Z; Lou Y
    Exp Ther Med; 2020 Dec; 20(6):170. PubMed ID: 33093907
    [TBL] [Abstract][Full Text] [Related]  

  • 19. p27(Kip1) Knockout mice are protected from diabetic nephropathy: evidence for p27(Kip1) haplotype insufficiency.
    Wolf G; Schanze A; Stahl RA; Shankland SJ; Amann K
    Kidney Int; 2005 Oct; 68(4):1583-9. PubMed ID: 16164635
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasminogen activator inhibitor-1 deficiency retards diabetic nephropathy.
    Nicholas SB; Aguiniga E; Ren Y; Kim J; Wong J; Govindarajan N; Noda M; Wang W; Kawano Y; Collins A; Hsueh WA
    Kidney Int; 2005 Apr; 67(4):1297-307. PubMed ID: 15780082
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.